Pathophysiology of antipsychotic drug-induced movement disorders.
about
Second-generation antipsychotics and extrapyramidal adverse effectsPharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for cliniciansPharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genesAripiprazole in Tardive Dyskinesia: Is it a Safe Choice?Animal models of focal dystonia.Risperidone and olanzapine induced tardive dyskinesia : a critical review of reported casesGray matter abnormalities in schizophrenia patients with tardive dyskinesia: a magnetic resonance imaging voxel-based morphometry study.Schizophrenia proteomics: biomarkers on the path to laboratory medicine?Preliminary Examination of Olanzapine and Diet Interactions On Metabolism in a Female MacaqueCommentary: Dopaminergic dysfunction in DYT1 dystonia.Case files of the University of California San Francisco Medical Toxicology Fellowship: lamotrigine toxicityMicroPET investigation of chronic long-term neurotoxicity from heavy ion irradiation.Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations.Treating bipolar disorder in the primary care setting: the role of aripiprazole.Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacologyMolecular pathways in dystonia.Emerging common molecular pathways for primary dystonia.Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales
P2860
Q21284676-092844BD-EC45-497E-B14D-AF2AD089D05CQ24657338-40812A48-7BD6-4A1D-8DE7-FB9667B3472EQ28088705-6F11E5A8-3137-4C63-A6E2-A58511C493F9Q33595007-75362C6F-8F33-4DE6-81AD-5BB2EF111573Q33844761-7DFDD386-F1AD-4DC9-B182-31B9A356A995Q34180344-DB59916C-1318-4EC9-85AC-A2BE276F6403Q34963355-D437C269-3575-461D-8205-759D3914A016Q34973585-9DDED2DA-7B73-4328-BC5A-92589D7DE4D2Q34993531-9BB11650-F53B-4846-8197-129407D066DAQ35009095-4E9D9DD0-DA27-42E9-B4EA-32FE874A8FE1Q36548936-2FD94F9C-5BC1-4126-8CC8-3641BC8CF1C7Q36616325-D77DC846-2828-4E56-82C2-6131A4ACE02FQ36806137-78258F7F-739B-455F-B76E-A2C7EC0FA693Q37429721-EDF7845E-EC3D-4AF9-A106-752A8BC282BFQ37705423-E3867019-D7C0-435C-9092-4EAA106D08BCQ37816579-26EF5717-47AB-4A14-93DF-C711C3232751Q38124786-9C3C1934-213C-4AB1-9C68-82C198DBE055Q40791623-AF48C705-62C2-4600-BDA6-5385D6B80351
P2860
Pathophysiology of antipsychotic drug-induced movement disorders.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pathophysiology of antipsychotic drug-induced movement disorders.
@ast
Pathophysiology of antipsychotic drug-induced movement disorders.
@en
type
label
Pathophysiology of antipsychotic drug-induced movement disorders.
@ast
Pathophysiology of antipsychotic drug-induced movement disorders.
@en
prefLabel
Pathophysiology of antipsychotic drug-induced movement disorders.
@ast
Pathophysiology of antipsychotic drug-induced movement disorders.
@en
P1476
Pathophysiology of antipsychotic drug-induced movement disorders
@en
P2093
Daniel E Casey
P478
65 Suppl 9
P577
2004-01-01T00:00:00Z